Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panorama Research Institute
Sunnyvale, California, United Statespano.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Preclinical
01
Overview
PRI has contributed to the development of several FDA-approved drugs—including memantine for Alzheimer’s disease—and has spun out over two dozen biotech companies. Its projects have led to seven IPOs and numerous acquisitions. The institute specializes in early-stage translational research with a focus on monoclonal antibodies and small molecules across oncology, neurology, immunology, cardiovascular/metabolic disorders.
- Therapeutic areas
- OncologyMetabolic DisordersImmunologyCardiovascularNeurology
- Modalities
- Monoclonal antibodyAntibody-drug conjugate (via portfolio companies)Small molecule (e.g., memantine)Recombinant protein (via portfolio companies)
- Industry
- Biotech
02
Partnerships
Cantargia AB – collaboration on humanized monoclonal antibodies targeting IL1RAP for cancer therapy.Amgen, Merck & Boehringer Ingelheim – service clients for scientific support.Merz & Forest Labs – partnered in initial development of memantine/Namenda.National Institutes of Health – grant funding recipient.Department of Energy & National Science Foundation – grant funding recipient.Other partnerships through licensing/incubation activities.
Beyond the preview
Go deeper on Panorama Research Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Panorama Research Institute.